Roquefort Therapeutics raises £300,000 to fund cancer drug acquisition
PositiveFinancial Markets

Roquefort Therapeutics has successfully raised £300,000 to fund the acquisition of a promising cancer drug. This funding is crucial as it allows the company to advance its mission of developing innovative treatments for cancer patients. The investment reflects growing confidence in the potential of new therapies to improve patient outcomes, making it a significant step forward in the fight against cancer.
— Curated by the World Pulse Now AI Editorial System